{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:50:02Z","timestamp":1761058202499},"reference-count":9,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2004,9,21]],"date-time":"2004-09-21T00:00:00Z","timestamp":1095724800000},"content-version":"vor","delay-in-days":4281,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chirality"],"published-print":{"date-parts":[[1993,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The enantiomers of the antiinflammatory drug Etodolac were separated without derivatization on Chiralcel OD and Pirkle (R)\u2010DNBPG columns. Enantiomeric purity can be determined in less than 10 min. Optimization of separation was evaluated using various concentrations of 2\u2010propanol (doped with TFA) in hexane as the mobile phase. \u00a9 1993 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/chir.530050311","type":"journal-article","created":{"date-parts":[[2005,1,7]],"date-time":"2005-01-07T11:02:10Z","timestamp":1105095730000},"page":"164-167","source":"Crossref","is-referenced-by-count":15,"title":["Direct high\u2010performance liquid chromatography (HPLC) separation of etodolac enantiomers using chiral stationary phases"],"prefix":"10.1002","volume":"5","author":[{"given":"Salvatore","family":"Caccamese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,9,21]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00155a047"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00366a025"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/chir.530040407"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600771114"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)83539-2"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600720316"},{"key":"e_1_2_1_8_2","first-page":"403","article-title":"Quantitative highperformance liquid chromatographic determination of etodolac in pharmaceutical formulations","volume":"46","author":"Ficarra R.","year":"1991","journal-title":"Farmaco."},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1021\/cr00092a006"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(01)83736-5"}],"container-title":["Chirality"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fchir.530050311","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/chir.530050311","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T06:29:05Z","timestamp":1698301745000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/chir.530050311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,1]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1993,1]]}},"alternative-id":["10.1002\/chir.530050311"],"URL":"https:\/\/doi.org\/10.1002\/chir.530050311","archive":["Portico"],"relation":{},"ISSN":["0899-0042","1520-636X"],"issn-type":[{"value":"0899-0042","type":"print"},{"value":"1520-636X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,1]]}}}